Ranger Investment Management, L.P.
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1319691
DALLAS, TX
Position in LGND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$53,494,819
+$2,449,134 QoQ
Shares Held
267,943
-0.8% QoQ
Ownership
1.34%
of shares outstanding
% of Portfolio
3.89%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 88.51061606386433.ToString("F0")%
Shared 0.ToString("F0")%
None 11.48938393613567.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ranger Investment Management, L.P. holds $74,071,947 across 2 Biotechnology names. LGND ranks #1 (72.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
This page
|
267,943 | $53,494,819 | |
| 2 | ADMA |
Adma Biologics, Inc.
|
2,283,810 | $20,577,128 |
All Filings in LGND
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,494,819 | 267,943 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $51,045,685 | 269,983 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $48,773,727 | 275,340 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $34,106,842 | 300,025 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $19,986,062 | 190,090 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,808,265 | 82,205 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,404,056 | 83,965 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $5,762,962 | 68,395 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,760,995 | 51,450 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||